Release Date: 01/08/24 15:15 Summary: Director's Declaration - Vikram Rana (Price Sensitive) Price Sensitive: Yes Download Document 97.75KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status